Dermal and Ophthalmological Acceptability Assessment in Sensitive Skin

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a single-center, single-blind clinical study designed to evaluate the safety of the investigational product through dermatological and ophthalmological clinical assessments. A total of 33 female participants, aged 18 to 60 years, with a clinical diagnosis of sensitive skin confirmed by the Stinging Test, will be enrolled. Safety evaluations will be performed throughout the study period using standardized clinical assessments.
Epistemonikos ID: 58b4fa4e012a5e81f4325f7525fe0872b16e188a
First added on: Aug 19, 2026